Logo image of FROG

JFROG LTD (FROG) Stock Fundamental Analysis

NASDAQ:FROG - Nasdaq - IL0011684185 - Common Stock - Currency: USD

43.995  +0.09 (+0.22%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FROG. FROG was compared to 282 industry peers in the Software industry. While FROG has a great health rating, there are worries on its profitability. FROG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
FROG had a positive operating cash flow in the past year.
FROG had negative earnings in each of the past 5 years.
In the past 5 years FROG always reported a positive cash flow from operatings.
FROG Yearly Net Income VS EBIT VS OCF VS FCFFROG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of FROG (-6.83%) is comparable to the rest of the industry.
FROG's Return On Equity of -9.87% is in line compared to the rest of the industry. FROG outperforms 52.84% of its industry peers.
Industry RankSector Rank
ROA -6.83%
ROE -9.87%
ROIC N/A
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
FROG Yearly ROA, ROE, ROICFROG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

With a decent Gross Margin value of 76.06%, FROG is doing good in the industry, outperforming 70.21% of the companies in the same industry.
FROG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FROG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
FROG Yearly Profit, Operating, Gross MarginsFROG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FROG has more shares outstanding
FROG has more shares outstanding than it did 5 years ago.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FROG Yearly Shares OutstandingFROG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FROG Yearly Total Debt VS Total AssetsFROG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.52 indicates that FROG is not in any danger for bankruptcy at the moment.
FROG has a Altman-Z score of 8.52. This is amongst the best in the industry. FROG outperforms 80.50% of its industry peers.
There is no outstanding debt for FROG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.52
ROIC/WACCN/A
WACC8.93%
FROG Yearly LT Debt VS Equity VS FCFFROG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

FROG has a Current Ratio of 2.14. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
FROG has a better Current ratio (2.14) than 63.83% of its industry peers.
A Quick Ratio of 2.14 indicates that FROG has no problem at all paying its short term obligations.
FROG's Quick ratio of 2.14 is fine compared to the rest of the industry. FROG outperforms 64.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.14
FROG Yearly Current Assets VS Current LiabilitesFROG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

FROG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.11%, which is quite good.
FROG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 178.78% yearly.
The Revenue has grown by 21.65% in the past year. This is a very strong growth!
FROG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.56% yearly.
EPS 1Y (TTM)13.11%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)21.65%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%22.03%

3.2 Future

FROG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.89% yearly.
Based on estimates for the next years, FROG will show a quite strong growth in Revenue. The Revenue will grow by 14.27% on average per year.
EPS Next Y8.76%
EPS Next 2Y12.19%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue Next Year17.96%
Revenue Next 2Y16.54%
Revenue Next 3Y15.87%
Revenue Next 5Y14.27%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FROG Yearly Revenue VS EstimatesFROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
FROG Yearly EPS VS EstimatesFROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 63.76, the valuation of FROG can be described as expensive.
FROG's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.98. FROG is valued rather expensively when compared to this.
FROG is valuated quite expensively with a Price/Forward Earnings ratio of 53.78.
FROG's Price/Forward Earnings ratio is in line with the industry average.
FROG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 63.76
Fwd PE 53.78
FROG Price Earnings VS Forward Price EarningsFROG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

FROG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FROG is cheaper than 65.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.25
EV/EBITDA N/A
FROG Per share dataFROG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FROG does not grow enough to justify the current Price/Earnings ratio.
FROG's earnings are expected to grow with 17.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.28
PEG (5Y)N/A
EPS Next 2Y12.19%
EPS Next 3Y17.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FROG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JFROG LTD

NASDAQ:FROG (6/30/2025, 10:34:52 AM)

43.995

+0.09 (+0.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners78.16%
Inst Owner Change3.71%
Ins Owners13.64%
Ins Owner Change-0.9%
Market Cap5.04B
Analysts81.48
Price Target45.03 (2.35%)
Short Float %2.6%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.39%
Min EPS beat(2)19.67%
Max EPS beat(2)33.1%
EPS beat(4)4
Avg EPS beat(4)23.68%
Min EPS beat(4)2.88%
Max EPS beat(4)39.08%
EPS beat(8)8
Avg EPS beat(8)43.08%
EPS beat(12)12
Avg EPS beat(12)397.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.92%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)2.17%
Revenue beat(4)2
Avg Revenue beat(4)0.15%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)2.17%
Revenue beat(8)3
Avg Revenue beat(8)0.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.05%
Revenue beat(16)6
Avg Revenue beat(16)0.05%
PT rev (1m)0.89%
PT rev (3m)-2.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.64%
EPS NY rev (1m)0.02%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.36%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 63.76
Fwd PE 53.78
P/S 11.19
P/FCF 42.25
P/OCF 41.23
P/B 6.3
P/tB 13.49
EV/EBITDA N/A
EPS(TTM)0.69
EY1.57%
EPS(NY)0.82
Fwd EY1.86%
FCF(TTM)1.04
FCFY2.37%
OCF(TTM)1.07
OCFY2.43%
SpS3.93
BVpS6.98
TBVpS3.26
PEG (NY)7.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -9.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.06%
FCFM 26.48%
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 12.1%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 2.14
Altman-Z 8.52
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)19.73%
Cap/Depr(5y)42.11%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.11%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y8.76%
EPS Next 2Y12.19%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue 1Y (TTM)21.65%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%22.03%
Revenue Next Year17.96%
Revenue Next 2Y16.54%
Revenue Next 3Y15.87%
Revenue Next 5Y14.27%
EBIT growth 1Y-41.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.01%
EBIT Next 3Y39%
EBIT Next 5YN/A
FCF growth 1Y936.47%
FCF growth 3Y67.17%
FCF growth 5Y67.4%
OCF growth 1Y700.57%
OCF growth 3Y58.42%
OCF growth 5Y61.81%